메뉴 건너뛰기




Volumn 9, Issue 5, 2003, Pages 351-355

The role of low-molecular-weight heparins in the prevention and treatment of venous thromboembolism in cancer patients

Author keywords

Heparin; Low molecular weight heparin; Neoplasm; Prophylaxis; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; COUMARIN DERIVATIVE; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; TICLOPIDINE; TINZAPARIN; WARFARIN;

EID: 0041737639     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200309000-00002     Document Type: Review
Times cited : (16)

References (20)
  • 1
    • 0035668874 scopus 로고    scopus 로고
    • Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
    • Mismetti P, Laporte S, Darmon JY, et al.: Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001, 88:913-930.
    • (2001) Br J Surg , vol.88 , pp. 913-930
    • Mismetti, P.1    Laporte, S.2    Darmon, J.Y.3
  • 2
    • 0037111563 scopus 로고    scopus 로고
    • Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
    • Prandoni P, Lensing AW, Piccioli A, et al.: Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002, 100:3484-3488. This is the largest prospective cohort series reporting the incidence of recurrent thrombosis and bleeding in patients with and without cancer.
    • (2002) Blood , vol.100 , pp. 3484-3488
    • Prandoni, P.1    Lensing, A.W.2    Piccioli, A.3
  • 3
    • 0030751133 scopus 로고    scopus 로고
    • Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment
    • ENOXACAN Study Group
    • Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group. Br J Surg 1997, 84:1099-1103.
    • (1997) Br J Surg , vol.84 , pp. 1099-1103
  • 4
    • 0037187892 scopus 로고    scopus 로고
    • Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer
    • Bergqvist D, Agnelli G, Cohen AT, et al.: Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002, 346:975-980. This is the first randomized, controlled trial to examine the efficacy and safety of extending prophylaxis beyond hospitalization in patients undergoing surgery for cancer.
    • (2002) N Engl J Med , vol.346 , pp. 975-980
    • Bergqvist, D.1    Agnelli, G.2    Cohen, A.T.3
  • 5
    • 0041635601 scopus 로고    scopus 로고
    • Prolonged prophylaxis against venous thromboembolism with enoxaparin in patients undergoing surgery for malignancy: 1-Year survival study
    • Bergqvist D, Agnelli G, Cohen A, et al.: Prolonged prophylaxis against venous thromboembolism with enoxaparin in patients undergoing surgery for malignancy: 1-year survival study. Blood 2002, 100:502a.
    • (2002) Blood , vol.100
    • Bergqvist, D.1    Agnelli, G.2    Cohen, A.3
  • 6
    • 0036622940 scopus 로고    scopus 로고
    • Preventing thromboembolic complications in cancer patients after surgery: A role for prolonged thromboprophylaxis
    • Rasmussen MS: Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev 2002, 28:141-144.
    • (2002) Cancer Treat Rev , vol.28 , pp. 141-144
    • Rasmussen, M.S.1
  • 7
    • 0035822248 scopus 로고    scopus 로고
    • Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: A meta-analysis of the randomised trials
    • Eikelboom JW, Quinlan DJ, Douketis JD: Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001, 358:9-15.
    • (2001) Lancet , vol.358 , pp. 9-15
    • Eikelboom, J.W.1    Quinlan, D.J.2    Douketis, J.D.3
  • 8
    • 0035923406 scopus 로고    scopus 로고
    • Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: A systematic review
    • Hull RD, Pineo GF, Stein PD, et al.: Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med 2001, 135:858-869.
    • (2001) Ann Intern Med , vol.135 , pp. 858-869
    • Hull, R.D.1    Pineo, G.F.2    Stein, P.D.3
  • 9
    • 0034255417 scopus 로고    scopus 로고
    • The risk of venous thromboembolism is increased throughout the course of malignant glioma: An evidence-based review
    • Marras LC, Geerts WH, Perry JR: The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer 2000, 89:640-646.
    • (2000) Cancer , vol.89 , pp. 640-646
    • Marras, L.C.1    Geerts, W.H.2    Perry, J.R.3
  • 10
    • 0008592537 scopus 로고    scopus 로고
    • The continuing risk of venous thromboembolism following operation for glioma: Findings from the Glioma Outcomes Project
    • Anderson F, Huang W, Sullivan C, et al.: The continuing risk of venous thromboembolism following operation for glioma: findings from the Glioma Outcomes Project. Thromb Haemost 2001, 86(suppl):OC902.
    • (2001) Thromb Haemost , vol.86 , Issue.SUPPL.
    • Anderson, F.1    Huang, W.2    Sullivan, C.3
  • 11
    • 0034726370 scopus 로고    scopus 로고
    • Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: A meta-analysis
    • Iorio A, Agnelli G: Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med 2000, 160:2327-2332.
    • (2000) Arch Intern Med , vol.160 , pp. 2327-2332
    • Iorio, A.1    Agnelli, G.2
  • 12
    • 0036924295 scopus 로고    scopus 로고
    • Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis
    • Goldhaber SZ, Dunn K, Gerhard-Herman M, et al.: Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest 2002, 122:1933-1937.
    • (2002) Chest , vol.122 , pp. 1933-1937
    • Goldhaber, S.Z.1    Dunn, K.2    Gerhard-Herman, M.3
  • 13
    • 0021042689 scopus 로고
    • Incidence of post-operative deep vein thrombosis in gynaecological oncology
    • Crandon AJ, Koutts J: Incidence of post-operative deep vein thrombosis in gynaecological oncology. Aust N Z J Obstet Gynaecol 1983, 23:216-219.
    • (1983) Aust N Z J Obstet Gynaecol , vol.23 , pp. 216-219
    • Crandon, A.J.1    Koutts, J.2
  • 14
    • 0035690935 scopus 로고    scopus 로고
    • Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: A randomized trial
    • Maxwell GL, Synan I, Dodge R, et al.: Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial. Obstet Gynecol 2001, 98:989-995.
    • (2001) Obstet Gynecol , vol.98 , pp. 989-995
    • Maxwell, G.L.1    Synan, I.2    Dodge, R.3
  • 15
    • 0037067889 scopus 로고    scopus 로고
    • Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: A randomized controlled study
    • Meyer G, Marjanovic Z, Valcke J, et al.: Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch Intern Med 2002, 162:1729-1735. This is the first published, randomized trial to compare the efficacy and safety of LMWH with warfarin for the prevention of recurrent venous thrombosis in cancer patients.
    • (2002) Arch Intern Med , vol.162 , pp. 1729-1735
    • Meyer, G.1    Marjanovic, Z.2    Valcke, J.3
  • 16
    • 0037775584 scopus 로고    scopus 로고
    • Low-molecular-weight heparin versus coumarin for the prevention of recurrent venous thromboembolism in cancer
    • in press
    • Lee AYY, Levine MN, Baker RI, et al.: Low-molecular-weight heparin versus coumarin for the prevention of recurrent venous thromboembolism in cancer. New Engl J Med 2003, in press. This is the first publication to show superiority of low-molecular-weight heparin dalteparin over oral anticoagulant therapy for secondary prophylaxis in cancer patients with venous thromboembolism.
    • (2003) New Engl J Med
    • Lee, A.Y.Y.1    Levine, M.N.2    Baker, R.I.3
  • 17
    • 0037721211 scopus 로고    scopus 로고
    • A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months versus intravenous heparin followed by warfarin sodium
    • Hull RD, Pineo GF, Mah AF, et al.: A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months versus intravenous heparin followed by warfarin sodium. Blood 2002, 100:148a.
    • (2002) Blood , vol.100
    • Hull, R.D.1    Pineo, G.F.2    Mah, A.F.3
  • 18
    • 6844254566 scopus 로고    scopus 로고
    • A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis
    • Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group
    • Decousus H, Leizorovicz A, Parent F, et al.: A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998, 338:409-415.
    • (1998) N Engl J Med , vol.338 , pp. 409-415
    • Decousus, H.1    Leizorovicz, A.2    Parent, F.3
  • 19
    • 0034833886 scopus 로고    scopus 로고
    • Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy
    • Luk C, Wells PS, Anderson D, et al.: Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy. Am J Med 2001, 111:270-273.
    • (2001) Am J Med , vol.111 , pp. 270-273
    • Luk, C.1    Wells, P.S.2    Anderson, D.3
  • 20
    • 0038427887 scopus 로고    scopus 로고
    • Low molecular weight heparin therapy and survival in advanced cancer
    • Kakkar AK, Kadziola Z, Williamson RC, et al.: Low molecular weight heparin therapy and survival in advanced cancer. Blood 2002, 100:148a.
    • (2002) Blood , vol.100
    • Kakkar, A.K.1    Kadziola, Z.2    Williamson, R.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.